Click to cancel search
Login
Sign Up
Home Page
How It Works
Our Story
Symptom Checker
Second Opinion Finder
Newsroom
Partner With Us
MediFind Pro
FAQ
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
Submit Feedback
Advertising Policy
Privacy Policy
Terms & Conditions
Condition
Condition
Doctor
Symptom
Condition
Click to search for condition or expert
Login
Sign Up
Click to open main menu
Share
Share
Share
Click
Share
Share
Condition
Mucopolysaccharidosis Type 3
Overview
Condition 101
Find a Doctor
Latest Research
Clinical Trials
Latest Research
Latest Advance
Study
Condition:
Sanfilippo Syndrome Type A
Journal:
Molecular genetics and metabolism
Treatment Used:
Intrathecal Heparan-N-Sulfatase (HNS)
Number of Patients:
21
Published —
December 12, 2018
This study reported on the effectiveness , pharmacokinetics, safety, and tolerability of intrathecal (IT) administration of recombinant human heparan-N-sulfatase (rhHNS) in the treatment of Sanfilippo syndrome type A (mucopolysaccharidosis type IIIA), a lysosomal disorder associated with progressive neurodegeneration in early childhood.
